Innovative Medical Management (SHE:002173) signed on to Quanzhen Medical's series B funding deal, retaining an 18.5% stake after the financing.
The round brings in Sichuan Jiannengda Investment, which will inject 25 million yuan in exchange for 10% equity, according to a Wednesday filing with the Shenzhen bourse.
The medical services provider has waived its pre-emptive rights and supports a 5% employee stock option pool.
Shares of Innovative Medical Management were down 4% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments